Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...

A rare case has been reported of diffuse large B cell lymphoma (DLBCL) presenting initially ... Read more about DLBCL comorbidities Due to the patient’s abdominal discomfort, computed tomography (CT) ...

including lymphoma of the eye, occurs when genetic changes in DNA alter the behavior of immune cells. These mutations cause the cells to become dysfunctional in terms of their role in immunity. The ...

International Childhood Cancer Day aims to spread awareness about childhood cancers. Childhood cancers (0-14 years of age) comprise 4% of all reported cancers in the ICMR-NCDIR's national cancer ...

Intravascular large B-cell lymphoma (IVLBCL) is a rare type of non-Hodgkin’s lymphoma. Its symptoms can vary, making it difficult to diagnose. The outlook for people with IVLBCL is typically poor.

Non-Hodgkin's lymphoma (NHL) is a cancer of special white blood cells called lymphocytes, which help your body fight infections. It starts in your lymph system. Because this system runs throughout ...

A longitudinal multiomics analysis of a patient with multiple myeloma who developed peripheral T cell lymphoma after treatment with anti-BCMA CAR T cells and a GPRC5D-directed bispecific antibody ...

When your doctor talks to you about your B-cell lymphoma, they'll tell you what type you have. It's an important piece of info to get, because each type of this cancer acts differently and has its ...

"Patients with large B-cell lymphoma can face a challenging journey, with too many patients enduring multiple rounds of chemotherapy and even CAR-T therapy with limited success," said principal ...